Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells by Nieborowska-Skorska, Margaret, Sullivan, Katherine, Dasgupta, Yashodhara, Podszywalow-Bartnicka, Paulina, Hoser, Grazyna, Maifrede, Silvia, Martinez, Esteban, Di Marcantonio, Daniela, Bolton-Gillespie, Elisabeth, Cramer-Morales, Kimberly, Lee, Jaewong, Li, Min, Slupianek, Artur, Gritsyuk, Daniel, Cerny-Reiterer, Sabine, Seferynska, Ilona, Stoklosa, Tomasz, Bullinger, Lars, Zhao, Huaqing, Gorbunova, Vera, Piwocka, Katarzyna, Valent, Peter, Civin, Curt I, Muschen, Markus, Dick, John E, Wang, Jean Cy, Bhatia, Smita, Bhatia, Ravi, Eppert, Kolja, Minden, Mark D, Sykes, Stephen M, Skorski, Tomasz

Get full text

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas by Czyż, Małgorzata, Toma, Monika, Gajos-Michniewicz, Anna, Majchrzak, Kinga, Hoser, Grazyna, Szemraj, Janusz, Nieborowska-Skorska, Margaret, Cheng, Phil, Gritsyuk, Daniel, Levesque, Mitchell, Dummer, Reinhard, Sliwinski, Tomasz, Skorski, Tomasz

Get full text

IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors by Maifrede, Silvia, Martin, Kayla, Podszywalow-Bartnicka, Paulina, Sullivan-Reed, Katherine, Langer, Samantha K, Nejati, Reza, Dasgupta, Yashodhara, Hulse, Michael, Gritsyuk, Daniel, Nieborowska-Skorska, Margaret, Lupey-Green, Lena N, Zhao, Huaqing, Piwocka, Katarzyna, Wasik, Mariusz A, Tempera, Italo, Skorski, Tomasz

Get full text

IGH/MYC Translocation in Burkitt Lymphoma Is Associated with BRCA2 Deficiency and Synthetic Lethality By PARP1 Inhibitors by Maifrede, Silvia, Martin, Kayla, Podszywalow-Bartnicka, Paulina, Katherine, Sullivan, Langer, Samantha, Nejati, Reza, Dasgupta, Yashodhara, Gritsyuk, Daniel, Nieborowska-Skorska, Margaret, Lupey, Lena, Piwocka, Katarzyna, Wasik, Mariusz A, Tempera, Italo, Skorski, Tomasz

Get full text